|
1.
|
C SonnenscheinN OleaME PasanenAM
SotoNegative controls of cell proliferation: human prostate cancer
cells and androgensCancer Res493474378119892731169
|
|
2.
|
BJ LongDN GrigoryevIP NnaneY LiuYZ LingAM
BrodieAntiandrogenic effects of novel androgen synthesis inhibitors
on hormone-dependent prostate cancerCancer
Res6066306640200011118046
|
|
3.
|
JM HaynesM FrydenbergH
MajewskiTestosteroneand phorbol ester-stimulated proliferation in
human cultured prostatic stromal cellsCell
Signal13703709200110.1016/S0898-6568(01)00205-411602180
|
|
4.
|
Z CuligA HobischG BartschH KlockerAndrogen
receptor - an update of mechanisms of action in prostate cancerUrol
Res28211219200010.1007/s00240000011111011957
|
|
5.
|
TH LiH ZhaoY PengJ BeliakoffJD BrooksZ
SunA promoting role of androgen receptor in androgen-sensitive and
-insensitive prostate cancer cellsNucleic Acids
Res3527672776200710.1093/nar/gkm19817426117
|
|
6.
|
X YuanT LiH WangT ZhangM BaruaRA BorgesiGJ
BubleyML LuSP BalkAndrogen receptor remains critical for cell-cycle
progression in androgen-independent CWR22 prostate cancer cellsAm J
Pathol169682696200610.2353/ajpath.2006.05104716877366
|
|
7.
|
M BlanchereI BerthautMC PortoisC MestayerI
MowszowiczHormonal regulation of the androgen receptor expression
in human prostatic cells in cultureJ Steroid Biochem Mol
Biol66319326199810.1016/S0960-0760(98)00056-99749837
|
|
8.
|
C AvancesV GeorgetB TerouanneF OrioO
CussenotN MottetP CostaC SultanHuman prostatic cell line PNT1A, a
useful tool for studying androgen receptor transcriptional activity
and its differential subnuclear localization in the presence of
androgens and antiandrogensMol Cell
Endocrinol1841324200110.1016/S0303-7207(01)00669-4
|
|
9.
|
B PlanzQ WangSD KirleyM MarbergerWS
McDougalRegulation of keratinocyte growth factor receptor and
androgen receptor in epithelial cells of the human prostateJ
Urol166678683200110.1016/S0022-5347(05)66042-911458116
|
|
10.
|
K NakanoY FukaboriN ItohW LuM KanWL
McKeehanH YamanakaAndrogen-stimulated human prostate epithelial
growth mediated by stromal-derived fibroblast growth
factor-10Endocr J46405413199910.1507/endocrj.46.40510503993
|
|
11.
|
JT ArnoldX LiuJD AllenH LeKK McFannMR
BlackmanAndrogen receptor or estrogen receptor-beta blockade alters
DHEA-, DHT-, and E(2)-induced proliferation and PSA production in
human prostate cancer
cellsProstate6711521162200710.1002/pros.2058517503469
|
|
12.
|
P BerthonAS WallerJM VilletteL LoridonO
CussenotNJ MaitlandAndrogens are not a direct requirement for the
proliferation of human prostatic epithelium in vitroInt J
Cancer73910916199710.1002/(SICI)1097-0215(19971210)73:6%3C910::AID-IJC25%3E3.0.CO;2-69399675
|
|
13.
|
LE HeislerA EvangelouAM LewJ
TrachtenbergHP ElsholtzTJ BrownAndrogen-dependent cell cycle arrest
and apoptotic death in PC-3 prostatic cell cultures expressing a
full-length human androgen receptorMol Cell
Endocrinol1265973199710.1016/S0303-7207(96)03970-69027364
|
|
14.
|
D KrillJ StonerBR KonetyMJ BecichRH
GetzenbergDifferential effects of vitamin D on normal human
prostate epithelial and stromal cells in primary
cultureUrology54171177199910.1016/S0090-4295(99)00103-X10414747
|
|
15.
|
MO Joly-PharabozMC SoaveB NicolasF
MebarkiM RenaudO FouryY MorelJG AndreAndrogens inhibit the
proliferation of a variant of the human prostate cancer cell line
LNCaPJ Steroid Biochem Mol
Biol556776199510.1016/0960-0760(95)00155-S7577722
|
|
16.
|
MO Joly-PharabozA RuffionA RochL
Michel-CalemardJ AndreJ ChantepieB NicolasG PanayeInhibition of
growth and induction of apoptosis by androgens of a variant of
LNCaP cell lineJ Steroid Biochem Mol
Biol73237249200010.1016/S0960-0760(00)00076-511070352
|
|
17.
|
C ShaoY WangHH YueYT ZhangCH ShiF LiuTY
BaoZY YangJL YuanGX ShaoBiphasic effect of androgens on prostate
cancer cells and its correlation with androgen receptor coactivator
dopa decarboxylaseJ
Androl28804812200710.2164/jandrol.106.00215417581945
|
|
18.
|
P GeckJ SzeleiJ JimenezTM LinC
SonnenscheinA SotoExpression of novel genes linked to the
androgen-induced, proliferative shutoff in prostate cancer cellsJ
Steroid Biochem Mol
Biol63211218199710.1016/S0960-0760(97)00122-29459187
|
|
19.
|
IS SilvaDM MorschL UrnauerPM
SpritzerAndrogen-induced cell growth and c-myc expression in human
non-transformed epithelial prostatic cells in primary cultureEndocr
Res27153169200110.1081/ERC-10010717711428707
|
|
20.
|
IS BrumDM MorschA PozzobonVA BoeriG GeibPM
SpritzerAndrogen-dependent expression of c-jun and c-fos in human
non-transformed epithelial prostatic cells: association with cell
proliferationHormone Res60209214200310.1159/00007403314614224
|
|
21.
|
R ButtyanA ShabsighH PerlmanM
ColombelRegulation of apoptosis in the prostate gland by androgenic
steroidsTrends Endocrinol
Metab104754199910.1016/S1043-2760(98)00104-010322394
|
|
22.
|
MJ SolomonP KaldisRegulation of CDKs by
phosphorylationResults Probl Cell
Differ2279109199810.1007/978-3-540-69686-5_4
|
|
23.
|
S WagaGJ HannonD BeachB StillmanThe p21
inhibitor of cyclin-dependent kinases controls DNA replication by
interaction with PCNANature369574578199410.1038/369574a07911228
|
|
24.
|
CJ SherrJM RobertsCDK inhibitors: positive
and negative regulators of G1-phase progressionGenes
Dev1315011512199910.1101/gad.13.12.150110385618
|
|
25.
|
CN RobsonV GnanapragasamRL ByrneAT
CollinsDE NealTransforming growth factor-beta1 up-regulates p15,
p21 and p27 and blocks cell cycling in G1 in human prostate
epitheliumJ Endocrinol160257266199910.1677/joe.0.16002579924195
|
|
26.
|
S LuSY TsaiMJ TsaiMolecular mechanisms of
androgen-independent growth of human prostate cancer LNCaP-AI
cellsEndocrinology14050545059199910537131
|
|
27.
|
MT LingKW ChanCK ChooAndrogen induces
differentiation of a human papillomavirus 16 E6/E7 immortalized
prostate epithelial cell lineJ
Endocrinol170287296200110.1677/joe.0.170028711431162
|
|
28.
|
KF MacleodN SherryG HannonD BeachT TokinoK
KinzlerB VogelsteinT Jacksp53-dependent and independent expression
of p21 during cell growth, differentiation, and DNA damageGenes
Dev9935944199510.1101/gad.9.8.9357774811
|
|
29.
|
S DowningP JacksonP RussellMutations
within the tumor suppressor gene p53 are not confined to a late
event in prostate cancer progression: a review of the evidenceUrol
Oncol6103110200110.1016/S1078-1439(00)00119-811344000
|
|
30.
|
OW RokhlinAF TaghiyevNV GusevaRA GloverPM
ChumakovJE KravchenkoMB CohenAndrogen regulates apoptosis induced
by TNFR family ligands via multiple signaling pathways in
LNCaPOncogene2467736784200510.1038/sj.onc.120883316007156
|
|
31.
|
LG WangL OssowskiAC FerrariOverexpressed
androgen receptor linked to p21WAF1 silencing may be responsible
for androgen independence and resistance to apoptosis of a prostate
cancer cell lineCancer Res6175447551200111606392
|
|
32.
|
PM SpritzerIS SilvaIO OliveiraDM MorschG
CoralCulture of adult human prostatic epithelial cells: A
simplified method for obtaining primary culturesMed Sci
Res233793811995
|
|
33.
|
T MosmannRapid colorimetric assay for
cellular growth and survival: application to proliferation and
cytotoxicity assaysJ Immunol
Methods655563198310.1016/0022-1759(83)90303-46606682
|
|
34.
|
ME TaplinGJ BubleyTD ShusterME FrantzAE
SpoonerGK OgataHN KeerSP BalkMutation of the androgen-receptor gene
in metastatic androgen-independent prostate cancerN Engl J
Med33213931398199510.1056/NEJM1995052533221017723794
|
|
35.
|
M BradfordA rapid and sensitive method for
quantitation of microgram quanties of protein utilizing the
principle of protein-dye bindingAnal
Biochem72248255197610.1016/0003-2697(76)90527-3942051
|
|
36.
|
N OleaK SakabeAM SotoC SonnenscheinThe
proliferative effect of ‘anti-androgens’ on the androgen-sensitive
human prostate tumor cell line
LNCaPEndocrinology126145714631990
|
|
37.
|
B HeJ ChenZ BasrawalaH XinD ChoubeyThe
FXXLF motif mediates androgen receptor-specific interactions with
coregulatorsJ Biol
Chem2771022610235200210.1074/jbc.M11197520011779876
|
|
38.
|
TO ChanSE RittenhousePN TsichlisAKT/PKB
and other D3 phosphoinositide-regulated kinases: kinase activation
by phosphoinositide-dependent phosphorylationAnnu Rev
Biochem689651014199910.1146/annurev.biochem.68.1.965
|
|
39.
|
OW RokhlinAV GudkovS KwekRA GloverAS
GewiesMB Cohenp53 is involved in tumor necrosis
factor-alpha-induced apoptosis in the human prostatic carcinoma
cell line
LNCaPOncogene1919591968200010.1038/sj.onc.120345310773886
|
|
40.
|
EM BruckheimerK SpurgersNL WeigelC
LogothetisTJ McDonnellRegulation of Bcl-2 expression by
dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer
cellsJ
Urol16915531557200310.1097/01.ju.0000055140.91204.c712629413
|
|
41.
|
PV NantermetJ XuY YuP HodorD HolderS
AdamskiMA GentileDB KimmelS HaradaD GerholdIdentification of
genetic pathways activated by the androgen receptor during the
induction of proliferation in the ventral prostate glandJ Biol
Chem27913101322200410.1074/jbc.M31020620014576152
|
|
42.
|
OY KhanG FuA IsmailS SrinivasanX CaoY TuS
LuZ NawazMultifunction steroid receptor coactivator, E6-associated
protein, is involved in development of the prostate glandMol
Endocrinol20544559200610.1210/me.2005-011016254014
|
|
43.
|
JR ZhouL YuLF ZerbiniTA LibermannGL
BlackburnProgression to androgen-independent LNCaP human prostate
tumors: cellular and molecular alterationsInt J
Cancer110800806200410.1002/ijc.2020615170660
|
|
44.
|
SR SchwarzeY ShiVX FuPA WatsonDF
JarrardRole of cyclin-dependent kinase inhibitors in the growth
arrest at senescence in human prostate epithelial and uroepithelial
cellsOncogene2081848192200110.1038/sj.onc.120504911781834
|
|
45.
|
R LiS WagaGJ HannonD BeachB
StillmanDifferential effects by the p21 CDK inhibitor on
PCNA-dependent DNA replication and
repairNature371534537199410.1038/371534a07935768
|
|
46.
|
S LuG JensterDE EpnerAndrogen induction of
cyclin-dependent kinase inhibitor p21 gene: role of androgen
receptor and transcription factor Sp1 complexMol
Endocrinol14753760200010.1210/mend.14.5.046110809237
|
|
47.
|
S YehYC HuM RahmanHK LinCL HsuHJ TingHY
KangC ChangIncrease of androgen-induced cell death and androgen
receptor transactivation by BRCA1 in prostate cancer cellsProc Natl
Acad Sci USA971125611261200010.1073/pnas.19035389711016951
|
|
48.
|
S LuM LiuDE EpnerSY TsaiMJ TsaiAndrogen
regulation of the cyclin-dependent kinase inhibitor p21 gene
through an androgen response element in the proximal promoterMol
Endocrinol13376384199910.1210/mend.13.3.025410076995
|
|
49.
|
F AlimirahJ ChenZ BasrawalaH XinD
ChoubeyDU-145 and PC-3 human prostate cancer cell lines express
androgen receptor: implications for the androgen receptor functions
and regulationFEBS
Lett58022942300200610.1016/j.febslet.2006.03.04116580667
|
|
50.
|
JP CareyAJ AsirvathamO GalmTA GhogomuJ
ChaudharyInhibitor of differentiation 4 (Id4) is a potential tumor
suppressor in prostate cancerBMC
Cancer9173200910.1186/1471-2407-9-17319500415
|
|
51.
|
JD McConnellProstatic growth: new insights
into hormonal regulationBr J Urol7651019957544215
|
|
52.
|
A GotohT ShirakawaY WadaM FujisawaH OkadaS
KamidonoK HamadaThe growth inhibitory effect of p21 adenovirus on
androgen-dependent and -independent human prostate cancer cellsBJU
Int92314318200310.1046/j.1464-410X.2003.04318.x12887490
|
|
53.
|
H MiyakeA TolcherME GleaveAntisense Bcl-2
oligodeoxynucleotides inhibit progression to androgen-independence
after castration in the Shionogi tumor modelCancer
Res5940304034199910463603
|
|
54.
|
J ConcatoD JainE UchioH RischWW LiCK
WellsMolecular markers and death from prostate cancerAnn Intern
Med150595603200910.7326/0003-4819-150-9-200905050-0000519414838
|
